eddingpharm: exploring the dream of "healthy china" through internationalization and innovation

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

"internationalization" is a complex and dynamic process. it is not just about expanding the business scope of enterprises or organizations. more importantly, it requires them to adapt to the ever-changing environment and ultimately provide better solutions for the global market. as an innovative pioneer in the industry, eddingpharm has achieved remarkable results under the guidance of its internationalization strategy.

in june 2024, eddingpharm received formal approval from the national medical products administration, and its independently developed vispas® was approved to enter a new chapter in china's cardiovascular treatment field. this breakthrough innovation not only marks a huge progress in china's cardiovascular treatment field, but also reflects eddingpharm's concept of "patient-centered, innovation-driven development".

eddingpharm's internationalization journey started from the domestic market. by establishing a sound international supply chain management capability and integrating global high-quality resources, it has formed a strong r&d innovation network. they have in-depth cooperation with top international scientific research institutions and enterprises, continuously introduced and absorbed the world's advanced r&d technology and management experience, and promoted the continuous upgrading of their own technology platform and the rapid expansion of their r&d pipeline.

"internationalization" is crucial to the future development of eddingpharm. it is not only about expanding the market, but also about bringing the development of innovative drugs to a broader stage. eddingpharm is committed to upgrading its own technology platform to the world's leading level and continuously exploring new research and development areas to provide patients with more safe, effective and affordable innovative drugs.

as one of the important engines of "healthy china", eddingpharm actively practices the "patient-centric" concept, continuously increases r&d investment, expands r&d areas, and provides better solutions for chinese and global patients.